INC Research

Wierman appointed Theorem vice president of biopharmaceutical development

Monday, May 13, 2013 08:00 AM

Theorem Clinical Research, a King of Prussia, Penn.-based, mid-sized provider of comprehensive clinical research and development services, has appointed Connie Wierman as vice president of biopharmaceutical development. Wierman leads the company’s oncology therapeutic focus for the biopharmaceutical business unit.

More... »

SynteractHCR hires Bill Pierce and Richard Paul

Thursday, April 4, 2013 08:00 AM

SynteractHCR, a full-service CRO, has hired two new senior executives to support the company's growth on a global scale following its recent merger. SynteractHCR has appointed Bill Pierce as chief information officer and Richard Paul as chief medical officer and vice president medical/regulatory affairs.

More... »

INC Research appoints James Taylor as vice president of clinical development

Tuesday, March 19, 2013 08:00 AM

INC Research, a therapeutically focused global CRO, has appointed James Taylor as vice president of clinical development.

More... »

INC Research promotes Tierney to executive vice president, Asia/Pacific

Friday, March 1, 2013 02:47 PM

Therapeutically focused CRO INC Research has promoted Garth Tierney to executive vice president, Asia/Pacific, responsible for driving the strategic development and overall growth of Asia/Pacific clinical research operations. Tierney, who was INC Research’s regional general manager for Australia and Southeast Asia, co-founded Trident Clinical Research, an Australia-based CRO acquired by INC Research in 2011 after 14 years of operation.

More... »

Neurovance receives patent for EB-1020, initiates ADHD trial

Friday, February 22, 2013 01:59 PM

The United States Patent and Trademark Office (USPTO) has issued Neurovance, a Cambridge, Mass.-based company spun out of Euthymics Bioscience, a notice of allowance for a composition of matter patent for EB-1020, providing proprietary protection for EB-1020 through July 2026.

More... »

INC Research select goBalto to enhance clinical study startup solution

Monday, January 14, 2013 12:31 PM

INC Research, a therapeutically-focused CRO, has selected a global site activation solution from goBalto, a developer of new-generation web clinical research solutions. goBalto Tracker 2.0 is a secure, web-based platform that enables study teams to track and manage site activation activities in clinical trials.

More... »

INC Research strengthens leadership for strategic advisory services unit

Monday, December 10, 2012 01:44 PM

INC Research, a therapeutically focused CRO, has appointed Robert Ryan, PhD, as vice president of regulatory strategy, consulting and submissions. Ryan will provide global leadership to position INC Strategic Advisory Services as a market leader in regulatory consulting and submissions offerings.

More... »

INC Research launches strategic advisory services unit

Wednesday, December 5, 2012 12:02 PM

INC Research, a therapeutically focused CRO, has launched INC Research Strategic Advisory Services, a new global business unit dedicated to providing biopharmaceutical customers with world-class consulting capabilities in the areas of drug development and commercialization, regulatory consulting and submissions and quality assurance.

More... »

INC Research expands in South Korea

Monday, September 17, 2012 09:27 AM

INC Research, a therapeutically focused CRO based in Raleigh, N.C., has opened a facility in Seoul, South Korea to manage the growing demand for world-class clinical development programs.

More... »

INC Research wins IACET accreditation for corporate training

Tuesday, August 28, 2012 12:26 PM

Raleigh, N.C.-based INC Research, a therapeutically focused CRO, has been accredited as an authorized provider of the International Association of Continuing Education and Training (IACET), strengthening its corporate training programs. INC says it is the only global CRO authorized provider offering Continuing Education Units (CEUs) that qualify under the ANSI/IACET standard.

More... »